Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Barclays Sees Two Key Drivers Behind A Potential Tesla Q3 Delivery Beat

% of readers think this story is Fact. Add your two cents.


Barclays Sees Two Key Drivers Behind A Potential Tesla Q3 Delivery Beat

Tesla is expected to report third-quarter earnings in late October. 

Ahead of the release, Barclays autos analyst Dan Levy expects deliveries to “beat” consensus, driven by two key factors: stronger Full Self-Driving adoption and rising exports from Shanghai.

FSD

First, FSD uptake is increasingly relevant – not only in serving as the “consumer AV” element of Tesla’s AV push, but also in providing both a margin boost, and perhaps more importantly a volume boost to Tesla. Indeed, Tesla’s 2Q delivery beat was in part driven by North America, and we assume that with FSD uptake of 55% in the quarter, buyers are increasingly choosing Tesla because of FSD.

Asia Demand

Tesla is increasingly benefiting from its China exports. In our visit to Giga Shanghai last week as part of our China Autos fieldtrip (see here and here), we were reminded of Tesla’s significant cost advantage in Shanghai. We believe exports from Shanghai may be at least 20% of Tesla’s global volume this year, and many rest-of-world markets which had previously been afterthoughts (i.e. Australia, Colombia, Asia ex-China) are now providing key volume boosts.

Levy estimates Tesla will deliver about 475,000 vehicles, above Wall Street consensus of roughly 466,000 and above his previous forecast of 450,000. However, that would represent a decline of about 4% from a year earlier and 1% from the second quarter.

Tesla is tracking toward 1.8 million deliveries for this year, up 10% from last year but back to its 2023 peak. 

“We believe a solid 3Q deliveries result would be a further validation point that Tesla’s vehicle growth has inflected positively, which became more evident after the significant 2Q delivery beat (480k vs cons 406k). Recall, at 2Q mgmt noted Tesla exited the quarter with its largest backlog since 2023, implying the potential for further growth ahead. We now turn to 3Q commentary for reads as to whether mgmt continues to see robust demand ahead,” Levy said. 

Barclays regional TSLA deliveries forecast

Levy pointed out that a delivery beat would not translate into stronger margins. He expects automotive gross margin, excluding regulatory credits and including stock-based compensation, to remain flat or edge below the second quarter’s 16.3%.

Tesla shares have slumped 18% year to date as of early Friday morning.

Wall Street analysts tracked by Bloomberg have assigned 29 “Buy” ratings, 24 “Hold” ratings and 8 “Sell” ratings, with an average 12-month price target of $391.

Looking ahead, there has been Tesla-SpaceX merger rumors this summer (read full report). 

Tyler Durden Fri, 09/18/2026 – 14:00


Source: https://freedombunker.com/2026/09/18/barclays-sees-two-key-drivers-behind-a-potential-tesla-q3-delivery-beat/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login